Answer
Xolair (omalizumab) is used as add-on therapy with intranasal corticosteroids to treat severe chronic rhinosinusitis with nasal polyps in adults aged 18 years and above whose disease is inadequately controlled by intranasal corticosteroids.
Sources for this answer
- Xolair 150mg Solution for Injection in pre-filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 22Document updated
Sources checked